New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings. A new article published in BJS (British Journal of Surgery) gives an overview of the major clinical trials and recommendations related to these new agents and will serve as a practical guide for their use in patients who require planned or emergency surgery.
Warfarin has been the drug of choice to control blood clots in a variety of patients, including people with certain types of irregular heartbeats, people with prosthetic heart valves, and people who have suffered heart attacks. Unfortunately, warfarin has serious side-effects, requires frequent monitoring to reduce the risk of bleeding, and has interactions with multiple drugs and foods. New oral anticoagulant drugs—Apixaban, Dabigatran, and Rivaroxaban —offer safer alternatives to warfarin, but there are currently no markers for measuring activity levels of the drugs and there are no antidotes to reverse or neutralize their effects.
Aida Lai, MBChB, of the North Bristol NHS Trust in the UK, and her colleagues searched the medical literature and analysed studies published between January 2000 and January 2014 that reported on the use of new oral anticoagulant drugs. "As these drugs are still relatively new in the market, knowledge about how they work and their associated bleeding risks are still limited in the medical and surgical community," said Dr Lai. "Our review covers recommendation for the discontinuation of new oral anticoagulant drugs before surgical procedures and resuming of these drugs after procedures." The review also notes that because the drugs are eliminated by the kidneys, they require dose reductions dependent on a patient's kidney function. Also, new oral anticoagulants are not recommended in patients with severe liver dysfunction. And because the three drugs have somewhat different properties, one of the drugs may be better suited to a particular patient than the others.
"It is anticipated that in the near future these drugs would replace warfarin to a large extent," said Dr Lai. "Therefore our article is highly relevant to surgeons and any medical professional treating patients on these drugs."
Explore further: Taking blood thinners with certain painkillers may raise bleeding risk
More information: "Perioperative management of patients on new oral anticoagulants." A. Lai, N. Davidson, S. W. Galloway, and J. Thachil. BJS; Published Online: April 29th, 2014 DOI: 10.1002/bjs.9485
Medical Xpress on facebook
Related Stories
Taking blood thinners with certain painkillers may raise bleeding risk
Apr 15, 2014
(HealthDay)—People taking blood thinners to prevent clots in their legs or lungs may put themselves at risk for serious internal bleeding if they also take common painkillers such as aspirin or ibuprofen, ...
Weighing up blood-thinners: Is warfarin always the best choice?
Oct 17, 2013
Patients who are responding below par to the anticoagulant drug warfarin have several options. They can undergo even more blood tests to monitor their response to the different dosages of this medication which is prescribed ...
People with irregular heartbeat should take blood thinners to prevent stroke
Feb 24, 2014
An updated guideline from the American Academy of Neurology recommends that people with nonvalvular atrial fibrillation, or irregular heartbeat, take oral anticoagulants, a type of blood thinner pill, to prevent stroke. The ...
Aspirin still overprescribed for stroke prevention in atrial fibrillation
Jan 28, 2014
Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.
Stroke risk high when anti-clotting drugs stopped
Apr 25, 2012
Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging ...
Recommended for you
Wrong-level localization in spine surgey rare but still occurs
4 hours ago
(HealthDay)—Most surgeons admit wrong-level localization during spinal surgery during their career, according to a study published in the May 1 issue of The Spine Journal.
Technological advancements extend survival of transplanted hearts across species
9 hours ago
Cardiac transplantation is the treatment of choice for end stage heart failure. According to the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, approximately 3,000 people in the US ...
Studies offer insight on how to improve kidney and liver transplantation
13 hours ago
The quality of kidney and liver donations is fundamentally important for the longevity of transplants and the health of recipients. That's why it's critical to know which organs are suitable for transplantation, as well as ...
Applying lessons from NASA helps manage threats and errors in pediatric cardiac surgery
15 hours ago
All high-stakes industries that function at very high "6-sigma" safety levels have a pre-occupation with human error. The aviation industry epitomizes this concept; during the 1970s NASA and aviation researchers ...
Complications from kidney stone treatments are common and costly
16 hours ago
Despite their overall low risk, procedures to treat kidney stones lead to complications that require hospitalization or emergency care for one in seven patients, according to researchers at Duke Medicine.
Patients report high satisfaction with pain treatment
Apr 28, 2014
An international research group with members from the University of Basel, several EU countries, Israel and the USA, analyzed patient satisfaction with pain treatment after surgery. The study based on an extensive multi-national ...
User comments
© Medical Xpress 2011-2014, Science X network
New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings. A new article published in BJS (British Journal of Surgery) gives an overview of the major clinical trials and recommendations related to these new agents and will serve as a practical guide for their use in patients who require planned or emergency surgery.
Warfarin has been the drug of choice to control blood clots in a variety of patients, including people with certain types of irregular heartbeats, people with prosthetic heart valves, and people who have suffered heart attacks. Unfortunately, warfarin has serious side-effects, requires frequent monitoring to reduce the risk of bleeding, and has interactions with multiple drugs and foods. New oral anticoagulant drugs—Apixaban, Dabigatran, and Rivaroxaban —offer safer alternatives to warfarin, but there are currently no markers for measuring activity levels of the drugs and there are no antidotes to reverse or neutralize their effects.
Aida Lai, MBChB, of the North Bristol NHS Trust in the UK, and her colleagues searched the medical literature and analysed studies published between January 2000 and January 2014 that reported on the use of new oral anticoagulant drugs. "As these drugs are still relatively new in the market, knowledge about how they work and their associated bleeding risks are still limited in the medical and surgical community," said Dr Lai. "Our review covers recommendation for the discontinuation of new oral anticoagulant drugs before surgical procedures and resuming of these drugs after procedures." The review also notes that because the drugs are eliminated by the kidneys, they require dose reductions dependent on a patient's kidney function. Also, new oral anticoagulants are not recommended in patients with severe liver dysfunction. And because the three drugs have somewhat different properties, one of the drugs may be better suited to a particular patient than the others.
"It is anticipated that in the near future these drugs would replace warfarin to a large extent," said Dr Lai. "Therefore our article is highly relevant to surgeons and any medical professional treating patients on these drugs."
Explore further: Taking blood thinners with certain painkillers may raise bleeding risk
More information: "Perioperative management of patients on new oral anticoagulants." A. Lai, N. Davidson, S. W. Galloway, and J. Thachil. BJS; Published Online: April 29th, 2014 DOI: 10.1002/bjs.9485
Medical Xpress on facebook
Related Stories
Taking blood thinners with certain painkillers may raise bleeding risk
Apr 15, 2014
(HealthDay)—People taking blood thinners to prevent clots in their legs or lungs may put themselves at risk for serious internal bleeding if they also take common painkillers such as aspirin or ibuprofen, ...
Weighing up blood-thinners: Is warfarin always the best choice?
Oct 17, 2013
Patients who are responding below par to the anticoagulant drug warfarin have several options. They can undergo even more blood tests to monitor their response to the different dosages of this medication which is prescribed ...
People with irregular heartbeat should take blood thinners to prevent stroke
Feb 24, 2014
An updated guideline from the American Academy of Neurology recommends that people with nonvalvular atrial fibrillation, or irregular heartbeat, take oral anticoagulants, a type of blood thinner pill, to prevent stroke. The ...
Aspirin still overprescribed for stroke prevention in atrial fibrillation
Jan 28, 2014
Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.
Stroke risk high when anti-clotting drugs stopped
Apr 25, 2012
Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging ...
Recommended for you
Wrong-level localization in spine surgey rare but still occurs
4 hours ago
(HealthDay)—Most surgeons admit wrong-level localization during spinal surgery during their career, according to a study published in the May 1 issue of The Spine Journal.
Technological advancements extend survival of transplanted hearts across species
9 hours ago
Cardiac transplantation is the treatment of choice for end stage heart failure. According to the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, approximately 3,000 people in the US ...
Studies offer insight on how to improve kidney and liver transplantation
13 hours ago
The quality of kidney and liver donations is fundamentally important for the longevity of transplants and the health of recipients. That's why it's critical to know which organs are suitable for transplantation, as well as ...
Applying lessons from NASA helps manage threats and errors in pediatric cardiac surgery
15 hours ago
All high-stakes industries that function at very high "6-sigma" safety levels have a pre-occupation with human error. The aviation industry epitomizes this concept; during the 1970s NASA and aviation researchers ...
Complications from kidney stone treatments are common and costly
16 hours ago
Despite their overall low risk, procedures to treat kidney stones lead to complications that require hospitalization or emergency care for one in seven patients, according to researchers at Duke Medicine.
Patients report high satisfaction with pain treatment
Apr 28, 2014
An international research group with members from the University of Basel, several EU countries, Israel and the USA, analyzed patient satisfaction with pain treatment after surgery. The study based on an extensive multi-national ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment